Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

ClinicalTrials.gov ID: NCT04421456

Public ClinicalTrials.gov record NCT04421456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted to evaluate the efficacy, safety, and tolerability of GWP42003-P versus placebo in participants with schizophrenia experiencing inadequate response to ongoing antipsychotic treatment.

Study identification

NCT ID
NCT04421456
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
95 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2020 (Actual)
Primary completion
Mar 16, 2022 (Actual)
Completion
Mar 16, 2022 (Actual)
Last update posted
Jun 15, 2023

2020 – 2022

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Clinical Trial Site Bentonville Arkansas 72712 —
Clinical Trial Site Little Rock Arkansas 72211-3702 —
Clinical Trial Site Garden Grove California 92845 —
Clinical Trial Site Lemon Grove California 91945 —
Clinical Trial Site Oakland California 94607-3900 —
Clinical Trial Site Pico Rivera California 90660-4920 —
Clinical Trial Site Largo Florida 33770 —
Clinical Trial Site Lauderhill Florida 33319 —
Clinical Trial Site Tampa Florida 33614 —
Clinical Trial Site Lincolnwood Illinois 60712 —
Clinical Trial Site Shreveport Louisiana 71101 —
Clinical Trial Site St Louis Missouri 63118 —
Clinical Trial Site Las Vegas Nevada 89102 —
Clinical Trial Site Berlin New Jersey 08009 —
Clinical Trial Site Cedarhurst New York 11516 —
Clinical Trial Site New York New York 10035 —
Clinical Trial Site Rochester New York 14618 —
Clinical Trial Site Beachwood Ohio 44122 —
Clinical Trial Site Richardson Texas 75080 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04421456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2023 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04421456 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →